Figure 3.
Comparison of overall survival rates according to expression of MET and RON (MET − and RON − vs either MET + or RON +) in patients with diffuse large B‐cell lymphoma with a low international prognostic index (IPI) (<3) (a) or a high IPI (≥3) (b), or in patients with germinal center B‐cell (GCB)‐like type (c) or non‐GCB‐like type of disease (d).